State MD
Clinical Trials in Maryland
Recruiting clinical trials with at least one study location in Maryland. Data updated daily from ClinicalTrials.gov.
Top Conditions in Maryland
NCT06462196 N/A
Recruiting
Natural History of Depression, Bipolar Disorder and Suicide Risk
Condition
Behavioral Symptoms
Enrollment
500 pts
Location
United States
Sponsor
National Institute of Mental H
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06990529 Phase 2
Recruiting
Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation
Condition
PIDs Linked to PI3K
Enrollment
12 pts
Location
United States, Spain
Sponsor
Pharming Technologies B.V.
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT05297279 N/A
Recruiting
OMEGA - Dietary Intervention - COPD Trial
Condition
COPD, Chronic Obstructive Pulmonary Disease
Enrollment
200 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06859073 Phase 1
Recruiting
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participan...
Condition
Healthy Volunteers
Enrollment
60 pts
Location
United States
Sponsor
Novo Nordisk A/S
NCT04410796 Phase 2
Recruiting
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Condition
Metastatic Non-small Cell Lung Cancer
Enrollment
571 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06504446 Phase 2
Recruiting
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With...
Condition
Refractory or Unexplained Chronic Cough
Enrollment
455 pts
Location
United States, Belgium, Canada
Sponsor
Nocion Therapeutics
NCT04614103 Phase 2
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Condition
Metastatic Non Small Cell Lung Cancer
Enrollment
170 pts
Location
United States, Australia, Canada
Sponsor
Iovance Biotherapeutics, Inc.
NCT06269627 Phase 4
Recruiting
Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Di...
Condition
Alcohol Use Disorder
Enrollment
48 pts
Location
United States
Sponsor
National Institute on Alcohol
NCT04442022 Phase 2, Phase 3
Recruiting
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without ...
Condition
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Enrollment
501 pts
Location
United States, Austria, China
Sponsor
Karyopharm Therapeutics Inc
NCT01499394 N/A
Recruiting
Caris Biorepository Research Protocol
Condition
Cancer
Enrollment
100,000 pts
Location
United States
Sponsor
Caris Science, Inc.
NCT03624374 N/A
Recruiting
Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Invo...
Condition
Leukoencephalopathies
Enrollment
100 pts
Location
United States
Sponsor
Hugo W. Moser Research Institu
NCT04181684 N/A
Recruiting
LITT Followed by Hypofractionated RT for Recurrent Gliomas
Condition
Glioblastoma
Enrollment
32 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT00943514 N/A
Recruiting
Natural History of Bronchiectasis
Condition
Bronchiectasis
Enrollment
900 pts
Location
United States
Sponsor
National Heart, Lung, and Bloo
NCT07075510 Phase 1, Phase 2
Recruiting
Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell D...
Condition
Plasma Cell Disorder
Enrollment
30 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT06637904 N/A
Recruiting
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Su...
Condition
Sepsis
Enrollment
300 pts
Location
United States
Sponsor
Inflammatix
NCT05638581 Phase 3
Recruiting
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Condition
Wounds and Injuries
Enrollment
1,100 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06290128 Phase 3
Recruiting
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inf...
Condition
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Enrollment
140 pts
Location
United States, Argentina, Belgium
Sponsor
Sanofi
NCT06858111 Phase 3
Recruiting
Fertilo In Vitro Research Study and Trial
Condition
In Vitro Maturation of Oocytes
Enrollment
500 pts
Location
United States
Sponsor
Gameto, Inc.
NCT05663034 N/A
Recruiting
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Trauma...
Condition
Traumatic Brain Injury
Enrollment
360 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05378347 N/A
Recruiting
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Condition
Abdominal Aortic Aneurysm
Enrollment
550 pts
Location
United States, Finland, France
Sponsor
Medtronic Cardiovascular
NCT01353547 N/A
Recruiting
Genes and Environment in Multiple Sclerosis
Condition
Multiple Sclerosis
Enrollment
5,000 pts
Location
United States
Sponsor
Columbia University
NCT07215858 Phase 2
Recruiting
BPL-1357 Against H1N1 Influenza Virus Challenge
Condition
Influenza
Enrollment
129 pts
Location
United States
Sponsor
National Institute of Allergy
NCT03375307 Phase 2
Recruiting
Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread...
Condition
Advanced Bladder Carcinoma
Enrollment
60 pts
Location
United States
Sponsor
National Cancer Institute (NCI